|
percent neurite outgrowth
|
BAO_0080013 |
|
|
percent neurite count
|
BAO_0080014 |
|
|
multiple endocrine neoplasia type 1
|
DOID_10017 |
|
|
nephrocalcinosis
|
DOID_12679 |
|
|
hypercalcemia
|
DOID_12678 |
|
|
calcium metabolism disease
|
DOID_10575 |
|
|
thyroid lymphoma
|
DOID_10011 |
|
|
thyroid gland cancer
|
DOID_1781 |
|
|
EC 1.10.3.2 (laccase) inhibitor
|
CHEBI_85050 |
|
|
EC 1.13.11.24 (quercetin 2,3-dioxygenase) inhibitor
|
CHEBI_85051 |
|
|
IC75
|
BAO_0001265 |
|
|
EC25
|
BAO_0001264 |
|
|
EC10
|
BAO_0001263 |
|
|
ED80
|
BAO_0001262 |
|
|
dosage endpoint
|
BAO_0002116 |
|
|
protease coupled enzyme activity measurement method
|
BAO_0002592 |
|
|
percent neurite branch point
|
BAO_0080015 |
|
|
TC50
|
BAO_0080016 |
|
|
ATP coupled enzyme activity measurement method
|
BAO_0002594 |
|
|
TCID50
|
BAO_0080017 |
|
